REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Difarmedic Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Difarmedic Cia.Ltda Profile Updated: February 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Difarmedic Cia.Ltda is an enterprise located in Ecuador, with the main office in Ibarra. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on February 11, 2019. There are currently 2 (2024) people employed by Difarmedic Cia.Ltda. From the latest financial highlights, Difarmedic Cia.Ltda reported a net sales revenue drop of 21.46% in 2024. Its’ total assets recorded a growth of 40.24%. The enterprise’s net profit margin increased by 1.15% in 2024.

Headquarters
Jaime Roldos Aguilera 3-70
Ibarra; Imbabura;

Contact Details: Purchase the Difarmedic Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Difarmedic Cia.Ltda report to view the information.
Registered Capital:
Purchase the Difarmedic Cia.Ltda report to view the information.
Financial Auditors:
Purchase the Difarmedic Cia.Ltda report to view the information.
Incorporation Date:
February 11, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
55%
Purchase this report to view the information.
45%
Company Performance
Financial values in the chart are available after Difarmedic Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-21.46%▼
Total operating revenue
-21.62%▼
Operating profit (EBIT)
3.56%▲
EBITDA
-3.03%▼
Net Profit (Loss) for the Period
53.03%▲
Total assets
40.24%▲
Total equity
32.8%▲
Operating Profit Margin (ROS)
0.96%▲
Net Profit Margin
1.15%▲
Return on Equity (ROE)
3.27%▲
Debt to Equity Ratio
-29.06%▼
Quick Ratio
0.53%▲
Cash Ratio
0.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo